Latest Breaking News On - Ivana magov - Page 3 : comparemela.com

Vigil Neuroscience Provides 2023 Year-in-Review and Highlights Upcoming 2024 Milestones

- On track to report interim Phase 1 data for VG-3927 in healthy volunteers in mid-2024 and Phase 2 results from IGNITE clinical trial evaluating iluzanebart in ALSP in Q3 2024 - - Extends projected.

Megan mcgrathIvana magovLeah gibsonKey clinical programEuropean commissionVigil neuroscience incInvestor relations corporate communicationsDrug administrationExchange commissionHealthcare conferenceChief executive officerClinical program highlightsInvestigational new drugCorporate highlightsVigil neuroscienceQuarterly report

Vigil Neuroscience (VIGL) Issues 2023 Update, Highlights 2024 Milestones

Vigil Neuroscience (VIGL) Issues 2023 Update, Highlights 2024 Milestones
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Ivana magovEuropean commissionVigil neuroscience incDrug administrationKey clinical programVigil neuroscienceChief executive officerClinical program highlightsInvestigational new drugCorporate highlightsHealthcare conference

Vigil Neuroscience Provides 2023 Year-in-Review and Highlights Upcoming 2024 Milestones

Vigil Neuroscience Provides 2023 Year-in-Review and Highlights Upcoming 2024 Milestones
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Leah gibsonMegan mcgrathIvana magovKey clinical programDrug administrationEuropean commissionInvestor relations corporate communicationsExchange commissionVigil neuroscience incHealthcare conferenceChief executive officerClinical program highlightsInvestigational new drugCorporate highlightsVigil neuroscienceQuarterly report

Vigil Neuroscience to Present at Evercore ISI 6th Annual HealthCONx Conference

WATERTOWN, Mass., Nov. 22, 2023 Vigil Neuroscience, Inc. , a clinical-stage biotechnology company committed to harnessing the power of microglia for the treatment of neurodegenerative diseases,.

Megan mcgrathDavid grayIvana magovLeah gibsonVigil neuroscience incInvestor relations corporate communicationsChief executive officerChief science officerInvestor relations

Vigil Neuroscience to Present at Evercore ISI 6th Annual HealthCONx Conference

Vigil Neuroscience to Present at Evercore ISI 6th Annual HealthCONx Conference
forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.

Ivana magovLeah gibsonMegan mcgrathDavid grayInvestor relations corporate communicationsVigil neuroscience incVigil neuroscienceChief executive officerChief science officerInvestor relations